Newmarket: Infection control company Tristel posts increase in half-year sales

INFECTION control and hygiene products company Tristel, which is based near Newmarket, yesterday reported a 13.4% increase in first-half sales.

Revenue for the six months to December 31 advanced to �4.565million, up from �4.027m during last year’s first half, with overseas sales more than doubling to �386,000.

Bottom line pre-tax profits were down 34% at �433,000, against �656,000 at last year’s half-way stage, but this reflected costs relating to expansion.

Gross margin, however, hardened from 63.1% to 65.5%, and the interim dividend will rise by 2.4%, from 0.425p to 0.435p per share.

Paul Swinney, chief executive at Tristel, said the company was pleased with its first-half sales performance.


You may also want to watch:


“We have focused our sales efforts on hospital departments such as ENT, urology and ultrasound as well as intensive care and isolation wards, and in these areas sales increased by 27.3%,” he said.

“Our drive into overseas markets continues to progress well, with sales up 147% on last year, with export sales representing 8.4% of group turnover in the period.”

Most Read

Mr Swinney added: “Overheads have been purposefully increased to provide the group with the infrastructure and platform for future growth.

“We have invested heavily in our expansion programme in the first half and look forward to an acceleration in turnover and growth in the second half in accordance with our internal plan and market expectations.”

Become a Supporter

This newspaper has been a central part of community life for many years. Our industry faces testing times, which is why we're asking for your support. Every contribution will help us continue to produce local journalism that makes a measurable difference to our community.

Become a Supporter
Comments powered by Disqus